Sunday, December 15, 2019

DT 8 / 2013

Big pharma reveals cost of goods for vaccine, changing rules of the game

The drug company GSK has agreed to sell cervical cancer vaccine to GAVI at no profit. This marks a sea change in GSK’s approach to transparency. But GAVI wants to drive prices down even more by bringing in other manufacturers.

Norconsult in new legal battle. Debarred by the World Bank, appeals verdict

Norconsult says the World Bank has decided to debar the firm due to corruption related to a project in Tanzania. The company has appealed. Meanwhile, the Supreme Court in Oslo has acquitted the firm.

Lake Turkana wind farm nears financial closure. Vestas lands turbine contract without tender

IFU and Norfund join forces with the African Development Bank to establish one of Africa’s largest wind projects. The turbine producer Vestas is on board as both project developer and supplier.

New SN Power. Stakraft loses majority, picks ripe projects worth billions

The owners of SN Power have restructured the firm. The majority owner Statkraft takes over the lion’s share of projects, while the “new” SN Power will focus on Africa, Southeast Asia and Central America.